Skip to content

ADMA Biologics ADMA ADMA Bio Manufacturing — Nonoperating Income Expense

Other segment segments

Plasma Collection Centers
$68K

Similar metrics at other companies

Apollo Global Management logo
APOAsset Management — Nonoperating Income (Expense)
-$97M-288%
AnaptysBio, Inc. logo
ANABBiopharma Company — Nonoperating Income Expense
$2.33M-43.0%
AnaptysBio, Inc. logo
ANABBiopharma Company — Other Nonoperating Income Expense
-$1K+85.7%
Pfizer logo
PFEBiopharma — Other Nonoperating Income (Expense)
$116M+48.7%
Starwood Property Trust logo
STWDCommercial and Residential Lending Segment — Nonoperating Income (Expense)
-$12.95M-166%
MoonLake Immunotherapeutics logo
MLTXOther Nonoperating Income
$3.21M-54.8%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's adma bio manufacturing — nonoperating income expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's ADMA bio manufacturing — nonoperating income expense?
ADMA Biologics (ADMA) reported ADMA bio manufacturing — nonoperating income expense of -$187K in Q1 2026.
How has ADMA Biologics's ADMA bio manufacturing — nonoperating income expense changed year-over-year?
ADMA Biologics's ADMA bio manufacturing — nonoperating income expense decreased by 192.2% year-over-year, from -$64K to -$187K.
What does ADMA bio manufacturing — nonoperating income expense mean?
Captures financial results from activities outside the segment's primary manufacturing operations, such as interest income, interest expense, or foreign exchange gains and losses. It helps isolate the impact of financing and peripheral activities from core business performance.